Sickle cell disease, while rare, is the most common inherited blood disorder and affects over 100,000 people in the United States, more than 90% of whom are Black according to the Centers for Disease ...

EpiFrontier Therapeutics, Inc., a biotechnology company developing transformative therapies for beta globin disorders, today announced its award of up to $32 million in non-dilutive funding from the ...

Please provide your email address to receive an email when new articles are posted on . Researchers at Boston Medical Center identified a new small molecule that could benefit people with sickle cell ...

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital ...

Michigan's health department announced a new plan to improve care and support for the 4,000 residents with sickle cell ...

Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...